Bernd-Wieland Kruger

This inventor holds 74 USPTO granted patents and 1 published patent application, primarily in Fungicide Development (CPC class 5144). Top assignees: Bayer Aktiengesellschaft, Saltigo Gmbh. Active years: 1983-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd-Wieland Kruger. Retrieved from https://idiyas.com/inventor/bernd-wieland-kruger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 74 (Patent Applications = 1)

% Patents Active = 98.6

Average Co-Inventor Count = 5.7

ph-index = 15

Forward Citations = 813(Granted Patents)

Forward Citations (Not Self Cited) = 773(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Wuppertal, DE (1983 - 1994)
Leverkusen, DE (1994)
Bergisch-Glabach, DE (1998)
Bergisch Gladbach, DE (1990 - 2001)
Gladbach, DE (1997 - 2013)

Company Filing History:

73 out of 12,268

Bayer Aktiengesellschaft

Years Active: 1983-2013

Loading Chart...

Areas of Expertise:

Fungicidal Compositions

Pyrimidine Derivatives

Aryl-Pyrrolidine Diones

Anthelmintics

Pesticidal Agents

Hydroxamic Acid Derivatives

Spiroheterocyclic Compounds

Alkoxyacrylic Acids

Amino Phenyl Carbamates

Arthropod Repellents

Azadioxacycloalkenes

Pyrazoline Derivatives

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8501775 - Anthelmintics for preventing parasitic infections in humans and animals (2013-08-06),

2. 6221810 - 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives (2001-04-24),

3. 6150521 - Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines (2000-11-21),

4. 6147091 - Arthropod repellant (2000-11-14),

5. 6103717 - Halogen pyrimidines and its use thereof as parasite abatement means (2000-08-15),

6. 6096751 - Substituted 1,2,3,4-tetrahydro-55-nitro-pyrimidines (2000-08-01),

7. 6071940 - Fungicidal active compound combinations (2000-06-06),

8. 6054621 - Alkoxyacrylic acid thiol esters used as fungicides (2000-04-25),

9. 6054459 - Substituted 1,2,3,4-tetrahydro-5-nitro-pyrimidines (2000-04-25),

10. 6008257 - Hydroxamic-acid derivatives, method of preparing them and their use as (1999-12-28),

11. 5981567 - Substituted spiroheterocyclic 1h-3-aryl-pyrrolidine-2,4-dione (1999-11-09),

12. 5962518 - Fungicidal active compound combinations (1999-10-05),

13. 5922762 - Fungicidal active compound combinations (1999-07-13),

14. 5883250 - Substituted azadioxacycloalkenes, fungicidal composition containing (1999-03-16),

15. 5869491 - Substituted 1,2,3,4-tetrahydro-5-nitro-pyrimidines (1999-02-09),

Title: Innovations and Contributions of Bernd-Wieland Kruger

Introduction: Bernd-Wieland Kruger, based in Bergisch Gladbach, Germany, is an accomplished inventor with a remarkable portfolio of 74 patents. His work primarily focuses on developing novel compositions and derivatives aimed at improving health outcomes for both humans and animals.

Latest Patents: Among his latest innovations are breakthrough patents in the field of pharmaceuticals. One significant invention is related to anthelmintics for preventing parasitic infections in humans and animals. This invention encompasses compositions that include specific active compounds designed to act as repellents against infections caused by parasitic flatworms (platyhelminths). Another noteworthy patent involves the development of new 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives, which present a promising avenue for further research and application.

Career Highlights: Throughout his career, Bernd-Wieland Kruger has made substantial contributions to the pharmaceutical industry. He has worked for prominent companies, including Bayer Aktiengesellschaft and Saltigo GmbH. His extensive experience in these organizations has equipped him with the knowledge and skills necessary to innovate and drive advancements in medical research.

Collaborations: Bernd-Wieland Kruger has collaborated with esteemed coworkers, notably Christoph Erdelen and Ulrike Wachendorff-Neumann. Together, they have combined their expertise to enhance the quality and scope of their research endeavors.

Conclusion: Bernd-Wieland Kruger is a notable figure in the realm of innovations and inventions, particularly in the development of health-related patents. His continued dedication to research and collaboration paves the way for future advancements in combating parasitic infections and enhancing therapeutic options.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: